Raed A. Alharbi
Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells
Alharbi, Raed A.; Pandha, Hardev S.; Simpson, Guy R.; Pettengell, Ruth; Poterlowicz, Krzysztof; Thompson, Alexander; Harrington, Kevin; El-Tanani, Mohamed; Morgan, Richard
Authors
Hardev S. Pandha
Guy R. Simpson
Ruth Pettengell
Krzysztof Poterlowicz
Dr ALEXANDER THOMPSON Alex.Thompson@nottingham.ac.uk
ASSOCIATE PROFESSOR
Kevin Harrington
Mohamed El-Tanani
Richard Morgan
Abstract
The HOX genes encode a family of transcription factors that have key roles in both development and malignancy. Disrupting the interaction between HOX proteins and their binding partner, PBX, has been shown to cause apoptotic cell death in a range of solid tumors. However, despite HOX proteins playing a particularly significant role in acute myeloid leukemia (AML), the relationship between HOX gene expression and patient survival has not been evaluated (with the exception of HOXA9), and the mechanism by which HOX/PBX inhibition induces cell death in this malignancy is not well understood. In this study, we show that the expression of HOXA5, HOXB2, HOXB4, HOXB9, and HOXC9, but not HOXA9, in primary AML samples is significantly related to survival. Furthermore, the previously described inhibitor of HOX/PBX dimerization, HXR9, is cytotoxic to both AML-derived cell lines and primary AML cells from patients. The mechanism of cell death is not dependent on apoptosis but instead involves a regulated form of necrosis referred to as necroptosis. HXR9-induced necroptosis is enhanced by inhibitors of protein kinase C (PKC) signaling, and HXR9 combined with the PKC inhibitor Ro31 causes a significantly greater reduction in tumor growth compared to either reagent alone.
Citation
Alharbi, R. A., Pandha, H. S., Simpson, G. R., Pettengell, R., Poterlowicz, K., Thompson, A., Harrington, K., El-Tanani, M., & Morgan, R. (2017). Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells. Oncotarget, 8(52), https://doi.org/10.18632/oncotarget.20023
Journal Article Type | Article |
---|---|
Acceptance Date | Jun 26, 2017 |
Publication Date | Aug 7, 2017 |
Deposit Date | Feb 13, 2018 |
Publicly Available Date | Feb 13, 2018 |
Journal | Oncotarget |
Electronic ISSN | 1949-2553 |
Publisher | Impact Journals |
Peer Reviewed | Peer Reviewed |
Volume | 8 |
Issue | 52 |
DOI | https://doi.org/10.18632/oncotarget.20023 |
Keywords | acute myeloid leukemia, HOX, HXR9, necroptosis, protein kinase C |
Public URL | https://nottingham-repository.worktribe.com/output/876867 |
Publisher URL | https://doi.org/10.18632/oncotarget.20023 |
Contract Date | Feb 13, 2018 |
Files
Morgan Oncotarget.pdf
(4.2 Mb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML
(2023)
Journal Article
The Use of Biomaterials in Internal Radiation Therapy
(2020)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search